| Price and Chart delayed at least 15 mintues. |
|
Price
$ 14.48
|
Change
0.00
|
|
Open
0.00
|
% Change
0.0%
|
|
Prev Close
14.48
|
Volume
NA
|
|
Market Value
98 bil
|
P/E Ratio
12.2
|
|
Bid
14.24
|
EPS
1.19
|
|
Ask
15.02
|
Dividend
0.64
|
|
High
0.00
|
Yield
4.4
|
|
Low
0.00
|
Shares Out
6.75 bil
|
|
52wk High
20.13
|
52wk Low
11.62
|
|
Industry: Drug Manufacturers - Major
|
|
Sector: Healthcare
|
PFE Profile
A research-based, global pharmaceutical company which discovers, develops, manufactures and markets prescription medicines for humans and animals.
Pfizer, Inc.
235 East 42nd Street New York, NY 10017-5755 Phone: (212) 573-2323 Fax: (212) 573-7851 Web Site: www.pfizer.com
PFE Wires Headlines
| 07.02.09 |
|
Final Glance: Pharmaceuticals companies
|
| 07.02.09 |
|
Midday Glance: Pharmaceuticals companies
|
| 07.02.09 |
|
RPT-UPDATE 3-J&J buys $1 bln Elan stake, gains Alzheimer's R&D
|
| 07.02.09 |
|
UPDATE 3-J&J buys $1 bln Elan stake, gains Alzheimer's R&D
|
| 07.02.09 |
|
Early Glance: Pharmaceuticals companies
|
More PFE From Wires Headlines >
Forbes.com on PFE RSS
|
|
|
Pfizer is ranked # 50 on the 2009 Forbes 2000 List
|
|
Thomson / IBES Earnings Estimates on PFE
Accounting Risk
Buy/Hold/Sell Analysis
Forbes Investment Guru Commentary on PFE
RSS News Feed on PFE
|
A D V E R T I S E M E N T
|